Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

37.82
+0.05000.13%
Post-market: 38.280.4648+1.23%19:27 EDT
Volume:1.65M
Turnover:62.96M
Market Cap:3.24B
PE:-8.71
High:39.27
Open:37.06
Low:36.66
Close:37.77
Loading ...

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Motley Fool
·
01 Apr

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers

Reuters
·
31 Mar

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Zacks
·
28 Mar

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

Simply Wall St.
·
28 Mar

CRISPR Therapeutics COO to Step Down

MT Newswires Live
·
27 Mar

Crispr Therapeutics COO Julianne Bruno to step down

TIPRANKS
·
27 Mar

Press Release: CRISPR Therapeutics Announces Transition of Chief Operating Officer

Dow Jones
·
27 Mar

Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis with Cardiomyopathy

GlobeNewswire
·
26 Mar

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Simply Wall St.
·
26 Mar

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey
·
26 Mar

2 Beaten-Down Stocks to Buy on the Dip

Motley Fool
·
23 Mar

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Zacks
·
21 Mar

Press Release: Editas Medicine Announces Chief Financial Officer Transition

Dow Jones
·
21 Mar

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

Zacks
·
19 Mar

Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?

Zacks
·
17 Mar

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

GlobeNewswire
·
13 Mar

Cathie Wood's Ark Invest Continues To Load Up On Tempus AI, Dumps Bitcoin-Focused Block In Tech Meltdown Aftermath

Benzinga
·
12 Mar

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

GlobeNewswire
·
06 Mar